Impact of clinical sample processing time on the performance and T-cell response of the T-SPOT.TB assay
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1912652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Yue Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of…. Hauptthemen laut MEDLINE: Interferon-gamma Release Tests, Tuberculosis, T-Lymphocytes, Mycobacterium tuberculosis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
T-SPOT. TB , an interferon-gamma release assay (IGRA) for detecting Mycobacterium tuberculosis infection, requires blood processing within 4 hours, limiting clinical flexibility. T-Cell Xtend™ (TCX) extends permissible storage but is costly. This study evaluated delayed processing impacts on T-SPOT. TB consistency in a real-world setting.
Methods
Outpatients undergoing T-SPOT. TB testing were prospectively enrolled. Samples were processed at standard timing (≤4 h), after 24-h delay with TCX, and after 24-h delay without TCX. Consecutive-day fresh samples served as within-subject reproducibility references.
Results
Among 443 patients, 282 underwent 24-h delayed testing. Agreement with standard-timing results was 93.3% without TCX (κ=0.859) and 93.0% with TCX (κ=0.860), comparable to fresh-sample reproducibility (95.0%; κ=0.840; all p<0.001). Multivariable analysis identified initial borderline results (OR = 15.21, p<0.001) and 24-h delay (p<0.05) as independent predictors of T-SPOT.TB reversion, regardless of TCX use. Antigen-well spot-forming cell (SFC) counts were significantly reduced after 24-h delay (p<0.001); TCX did not mitigate this decline (p=1.000). Positive-control SFC counts remained stable (p=0.602).
Conclusions
A 24-h processing delay demonstrated high concordance with standard-timing T-SPOT. TB results, supporting clinical feasibility. Nevertheless, borderline results and delayed processing were independently associated with result discordance, warranting cautious clinical interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Health Care, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network, Beijing, China.
- Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chang, Y., Ruan, G., Liu, Y., Zhou, B., Zhang, L., & Han, Y. (2026). Impact of clinical sample processing time on the performance and T-cell response of the T-SPOT.TB assay. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1912652
Vancouver
Chang Y, Ruan G, Liu Y, Zhou B, Zhang L, Han Y. Impact of clinical sample processing time on the performance and T-cell response of the T-SPOT.TB assay. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1912652
BibTeX
@article{Chang2026,
author = {Chang, Yue and Ruan, Guiren and Liu, Yaxu and Zhou, Baotong and Zhang, Lifan and Han, Yang},
title = {Impact of clinical sample processing time on the performance and T-cell response of the T-SPOT.TB assay},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1912652}
}
EUVIMED